2 lawmakers push for Avandia to be withdrawn from the market

06/28/2010 | Hill, The

A joint statement from Sen. Chuck Grassley, R-Iowa, and Rep. Rosa DeLauro, D-Conn., calls on the FDA to withdraw GlaxoSmithKline's Avandia from the market, after two studies confirmed that the drug poses serious risks in diabetics. The first study showed that Avandia increases patients' risk of heart attack, while the second study found that the drug raises the risk for stroke, heart failure and death.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA